Biocorp Production announced that it has received €2.5 million in funding from Vatel Capital SAS

Biocorp specializes in the development and manufacture of medical devices and drug delivery systems. The company offers traditional delivery systems, connected injection systems and monitoring devices. Net sales break down by source of income between sales of services (86.9%) and products (13.1%). At the end of 2022, Biocorp has a production site located in France. France accounts for 62.6% of net sales.